IDEAYA Biosciences (IDYA)
(Real Time Quote from BATS)
$38.16 USD
-1.34 (-3.39%)
Updated Sep 3, 2024 02:16 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Earnings News For IDYA
-
IDEAYA Biosciences, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. (IDYA) Expected to Beat Earnings Estimates: Should You Buy?
-
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q3 Loss, Lags Revenue Estimates
-
IDEAYA Biosciences, Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q2 Loss, Lags Revenue Estimates
-
IDEAYA Biosciences, Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q1 Loss, Misses Revenue Estimates
-
IDEAYA Biosciences, Inc. Reports First Quarter 2023 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. (IDYA) Expected to Beat Earnings Estimates: Should You Buy?
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q4 Loss, Misses Revenue Estimates
-
IDEAYA Biosciences, Inc. (IDYA) Q3 Earnings and Revenues Beat Estimates
-
IDEAYA Biosciences, Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q2 Loss, Misses Revenue Estimates
-
IDEAYA Biosciences, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. (IDYA) Expected to Beat Earnings Estimates: Should You Buy?
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q1 Loss, Tops Revenue Estimates
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q4 Loss, Misses Revenue Estimates
-
Earnings Preview: IDEAYA Biosciences, Inc. (IDYA) Q3 Earnings Expected to Decline
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q2 Loss, Misses Revenue Estimates
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q1 Loss, Misses Revenue Estimates
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q4 Loss, Lags Revenue Estimates
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q2 Loss, Misses Revenue Estimates